HuR in pheochromocytomas and paragangliomas - overexpression in verified malignant tumors

Clinical Significance of Hu-Antigen Receptor (HuR) and Cyclooxygenase-2 (COX-2) Expression in Human Malignant and Benign Thyroid Lesions

(2015) Constantinos Giaginis et al.   PATHOLOGY & ONCOLOGY RESEARCH

Malignant pheochromocytoma: a review

(2010) Avital Harari et al.   AMERICAN JOURNAL OF SURGERY

SDHB loss predicts malignancy in pheochromocytomas/sympathethic paragangliomas, but not through hypoxia signalling

(2010) Annika Blank et al.   ENDOCRINE-RELATED CANCER

Association between expression of embryonic lethal abnormal vision-like protein HuR and cyclooxygenase-2 in oral squamous cell carcinoma

(2010) Jeong-Dan Cha et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Posttranscriptional regulation of cancer traits by HuR

(2010) Kotb Abdelmohsen et al.   Wiley Interdisciplinary Reviews-RNA

The Role of HuR in Gemcitabine Efficacy in Pancreatic Cancer: HuR Up-regulates the Expression of the Gemcitabine Metabolizing Enzyme Deoxycytidine Kinase

(2009) C. L. Costantino et al.   CANCER RESEARCH

Expression of the embryonic lethal abnormal vision-like protein HuR in human mesothelioma

(2008) Daniela Stoppoloni et al.   CANCER